Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy
- PMID: 21909123
- PMCID: PMC4002725
- DOI: 10.1038/aps.2011.103
Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy
Abstract
The cell cycle, which is precisely controlled by a number of regulators, including cyclins and cyclin-dependent kinases (CDKs), is crucial for the life cycle of mammals. Cell cycle dysregulation is implicated in many diseases, including cancer. Recently, compelling evidence has been found that microRNAs play important roles in the regulation of cell cycle progression by modulating the expression of cyclins, CDKs and other cell cycle regulators. Herein, the recent findings on the regulation of the cell cycle by microRNAs are summarized, and the potential implications of miRNAs in anti-cancer therapies are discussed.
Figures
Similar articles
-
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.Cancer Cell. 2017 Apr 10;31(4):576-590.e8. doi: 10.1016/j.ccell.2017.03.004. Cancer Cell. 2017. PMID: 28399412 Free PMC article.
-
Cyclins and CDKS in development and cancer: lessons from genetically modified mice.Front Biosci. 2006 Jan 1;11:1164-88. doi: 10.2741/1871. Front Biosci. 2006. PMID: 16146805 Review.
-
Cyclins and related kinases in cancer cells.J BUON. 2007 Sep;12 Suppl 1:S45-52. J BUON. 2007. PMID: 17935277 Review.
-
Circular reasoning: microRNAs and cell-cycle control.Trends Biochem Sci. 2008 Oct;33(10):474-81. doi: 10.1016/j.tibs.2008.06.008. Epub 2008 Sep 5. Trends Biochem Sci. 2008. PMID: 18774719 Free PMC article. Review.
-
Altered miRNA expression in aniline-mediated cell cycle progression in rat spleen.Toxicol Mech Methods. 2017 Sep;27(7):511-517. doi: 10.1080/15376516.2017.1324932. Epub 2017 Jun 6. Toxicol Mech Methods. 2017. PMID: 28463034 Free PMC article.
Cited by
-
TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93.Clin Transl Oncol. 2014 Nov;16(11):986-92. doi: 10.1007/s12094-014-1185-7. Epub 2014 Sep 3. Clin Transl Oncol. 2014. PMID: 25183046
-
MiREDiBase, a manually curated database of validated and putative editing events in microRNAs.Sci Data. 2021 Aug 4;8(1):199. doi: 10.1038/s41597-021-00979-8. Sci Data. 2021. PMID: 34349127 Free PMC article.
-
MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.Int J Clin Exp Pathol. 2015 May 1;8(5):4745-54. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191164 Free PMC article.
-
Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells.Biomed Rep. 2022 Aug 3;17(4):78. doi: 10.3892/br.2022.1561. eCollection 2022 Oct. Biomed Rep. 2022. PMID: 36158319 Free PMC article.
-
An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis.Int J Mol Sci. 2023 Apr 14;24(8):7268. doi: 10.3390/ijms24087268. Int J Mol Sci. 2023. PMID: 37108432 Free PMC article. Review.
References
-
- Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501–12. - PubMed
-
- Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153–66. - PubMed
-
- He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522, 31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources